Statistical hypothesis testing

COVID Restrictions May Do More Harm than Good, States the Association of American Physicians and Surgeons (AAPS)

Retrieved on: 
Tuesday, July 20, 2021

The Association of American Physicians and Surgeons (AAPS) agrees that policy should be based on valid evidence, and makes the following statements:

Key Points: 
  • The Association of American Physicians and Surgeons (AAPS) agrees that policy should be based on valid evidence, and makes the following statements:
    Science is a method for discovering truth, based on observation, measurement, open inquiry, and hypothesis testing.
  • The Science is not equivalent to the opinion of a government official or bureaucracy.
  • Neither number is evidence-based, and if the virus is air-borne , ventilation and air disinfection are helpful measures.
  • The Association of American Physicians and Surgeons has represented physicians in all specialties since 1943.

Three Day Biostatistics for the Non-Statistician Seminar: A Non-mathematical Introduction to Biostatistics and is Designed for Non-statisticians - June 9-11, 2021 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 26, 2021

Statistics is a useful decision making tool in the clinical research arena.

Key Points: 
  • Statistics is a useful decision making tool in the clinical research arena.
  • However, these softwares were developed for statisticians and can often be daunting to non-statisticians.
  • How do you know if you are pressing the right key, let alone performing the best test?
  • This seminar provides a non-mathematical introduction to biostatistics and is designed for non-statisticians.

Squish Test Center 1.2 Released, with New Git Tie-In

Retrieved on: 
Thursday, April 15, 2021

b'HAMBURG, Germany, April 15, 2021 /PRNewswire-PRWeb/ --froglogic, a leader in professional software quality tooling, announced today the release of Squish Test Center version 1.2, its test result management and analysis platform supporting application development teams worldwide.

Key Points: 
  • b'HAMBURG, Germany, April 15, 2021 /PRNewswire-PRWeb/ --froglogic, a leader in professional software quality tooling, announced today the release of Squish Test Center version 1.2, its test result management and analysis platform supporting application development teams worldwide.
  • The version introduces major new features to the product as well as a wide range of stability improvements and performance optimizations to support test automation projects generating large amounts of test report data.\nTest Center now supports directly accessing test scripts and test data, like those stored in Git, through its new repository integration, greatly simplifying test report and root cause analysis.
  • With direct access to expected verification point data, screenshot verifications can be performed right in Test Center\'s web interface.\nImproved traceability support makes it easier than ever to integrate third party tools such as Jira or TestRail with Squish Test Center.
  • "Directly accessing the test repository and connecting test results to traceability items makes it easier than ever to get a comprehensive understanding of even the largest test reports," Kaufmann added.\nSquish Test Center 1.2 is available as of now: https://www.froglogic.com/news/test-center-12-now-available .

Biostatistics for the Non-Statistician Virtual 2 Day Seminar, April 28-30, 2021 - ResearchAndMarkets.com

Retrieved on: 
Friday, April 2, 2021

Statistics is a useful decision-making tool in the clinical research arena.

Key Points: 
  • Statistics is a useful decision-making tool in the clinical research arena.
  • How do you know if you are pressing the right key, let alone performing the best test?
  • This seminar provides a non-mathematical introduction to biostatistics and is designed for non-statisticians.
  • The goal of this seminar is to teach you enough statistics to:
    Understand the statistical portions of most articles in medical journals.

Can-Fite: Topical Administration of CF602 Fully Recovers Erectile Dysfunction in Diabetic Model

Retrieved on: 
Thursday, March 18, 2021

The study evaluated the efficacy of topically applied CF602 in a 4-cohort study with diabetic Sprague-Dawley (SD) rats receiving placebo; 100nM CF602; 500nM CF602.

Key Points: 
  • The study evaluated the efficacy of topically applied CF602 in a 4-cohort study with diabetic Sprague-Dawley (SD) rats receiving placebo; 100nM CF602; 500nM CF602.
  • Treatment with CF602 at a dose of 500 nM resulted in statistically significant improvement of erectile dysfunction compared to vehicle treated controls when measured in a two-way ANOVA followed by Bonferroni multiple comparisons post-hoc analysis (p
  • As a topical formulation, CF602 may offer distinct safety and efficacy advantages over oral ED drugs on the market today, stated Can-Fite CEO Dr. Pnina Fishman.
  • CF602, the Company's third drug candidate, has shown efficacy in the treatment of erectile dysfunction.

Eagle Alpha Is Proud To Present A Data Hackathon Competition - Taking Alternative Data To The Next Level For Investment Strategy

Retrieved on: 
Monday, February 22, 2021

Five teams will present their approach to data blending and alpha testing to arrive at a real-time macro framework as never before.

Key Points: 
  • Five teams will present their approach to data blending and alpha testing to arrive at a real-time macro framework as never before.
  • Niall Hurley, CEO of Eagle Alpha said "Eagle Alpha, as the leading alternative data aggregator, has evolved its thought leadership to provide a proof-of-concept framework to closely follow the needs of the market.
  • This one-of-a-kind event helps show how alternative data can demonstrate alpha which is imperative for funds investment strategies.
  • Their results will be measured in a real-time macro framework employing alternative data and the winning team will present at Eagle Alpha's March conference.

Eagle Alpha Is Proud To Present A Data Hackathon Competition - Taking Alternative Data To The Next Level For Investment Strategy

Retrieved on: 
Monday, February 22, 2021

Five teams will present their approach to data blending and alpha testing to arrive at a real-time macro framework as never before.

Key Points: 
  • Five teams will present their approach to data blending and alpha testing to arrive at a real-time macro framework as never before.
  • Niall Hurley, CEO of Eagle Alpha said "Eagle Alpha, as the leading alternative data aggregator, has evolved its thought leadership to provide a proof-of-concept framework to closely follow the needs of the market.
  • This one-of-a-kind event helps show how alternative data can demonstrate alpha which is imperative for funds investment strategies.
  • Their results will be measured in a real-time macro framework employing alternative data and the winning team will present at Eagle Alpha's March conference.

CAP Statement on Executive Actions Concerning COVID-19 Tests

Retrieved on: 
Thursday, January 21, 2021

College of American Pathologists (CAP) President Patrick Godbey, MD, FCAP, released the following statement on President Joe Bidens actions today to create a Pandemic Testing Board and address other issues concerning COVID-19 testing.

Key Points: 
  • College of American Pathologists (CAP) President Patrick Godbey, MD, FCAP, released the following statement on President Joe Bidens actions today to create a Pandemic Testing Board and address other issues concerning COVID-19 testing.
  • While 2 million tests are being provided every day, surveys of laboratory directors have consistently reported that more testing could be performed but their labs are constrained by several limitations.
  • Importantly, the presidents executive orders and actions today will also clear up any confusion that health insurance companies must cover tests provided to asymptomatic patients.
  • We must ensure that communities of color and vulnerable patient populations have equal access to tests, treatments, and therapeutics.

Perfecto by Perforce Releases Fall 2020 Test Coverage Index

Retrieved on: 
Tuesday, November 10, 2020

With fifteen years of industry-leading expertise in mobile app testing, Perfecto is proud to introduce this latest installment of the Test Coverage Index, its fourteenth edition.

Key Points: 
  • With fifteen years of industry-leading expertise in mobile app testing, Perfecto is proud to introduce this latest installment of the Test Coverage Index, its fourteenth edition.
  • Equipped with the data from the Test Coverage Index, teams can tackle a top challenge faced in testing today: strategizing their testing for the most complete test coverage possible.
  • That is why it is critical for teams to strategize their test coverage, considering not just the platforms but also the scenarios to test against.
  • "Our customers rely on the Test Coverage Index to craft their testing strategies, minimize risk, and reduce escaped defects," says Perfecto Chief Evangelist, Eran Kinsbruner.

Wuga's Web-App is Depolarizing Debate Around Politics

Retrieved on: 
Monday, November 2, 2020

HOUSTON, Nov. 2, 2020 /PRNewswire/ --The Wuga Web-App released their cure to heated discussions around politics.

Key Points: 
  • HOUSTON, Nov. 2, 2020 /PRNewswire/ --The Wuga Web-App released their cure to heated discussions around politics.
  • Wuga is a test designed to tell you where you stand on Economic, Diplomatic, Civil, and Social issues.
  • It was inspired by the Political Coordinates test, but Wuga says they have bigger plans for their application.
  • The founders believe that showing people their own values will help them make better decisions as voters, something more important now than ever.